Detalles de la búsqueda
1.
Targeting Inhibitor of κB Kinase ß Prevents Inflammation-Induced Preterm Delivery by Inhibiting IL-6 Production from Amniotic Cells.
Am J Pathol
; 186(3): 616-29, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26796146
2.
The Novel IκB Kinase ß Inhibitor, IMD-0560, Has Potent Therapeutic Efficacy in Ovarian Cancer Xenograft Model Mice.
Int J Gynecol Cancer
; 26(4): 610-8, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26905334
3.
Amelioration of endotoxin-induced uveitis treated with an IκB kinase ß inhibitor in rats.
Mol Vis
; 18: 2586-97, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23112571
4.
IMD-4690, a novel specific inhibitor for plasminogen activator inhibitor-1, reduces allergic airway remodeling in a mouse model of chronic asthma via regulating angiogenesis and remodeling-related mediators.
PLoS One
; 10(3): e0121615, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25785861
5.
IKKß Regulates VEGF Expression and Is a Potential Therapeutic Target for Ovarian Cancer as an Antiangiogenic Treatment.
Mol Cancer Ther
; 14(4): 909-19, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25637316
6.
IκB kinase-ß inhibitor IMD-0354 beneficially suppresses retinal vascular permeability in streptozotocin-induced diabetic mice.
Invest Ophthalmol Vis Sci
; 55(10): 6365-73, 2014 Sep 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-25205865
7.
The novel IκB kinase ß inhibitor IMD-0560 prevents bone invasion by oral squamous cell carcinoma.
Oncotarget
; 5(23): 12317-30, 2014 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25373602
Resultados
1 -
7
de 7
1
Próxima >
>>